BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 19907312)

  • 1. Mucus hypersecretion in asthma: intracellular signalling pathways as targets for pharmacotherapy.
    Lai HY; Rogers DF
    Curr Opin Allergy Clin Immunol; 2010 Feb; 10(1):67-76. PubMed ID: 19907312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New pharmacotherapy for airway mucus hypersecretion in asthma and COPD: targeting intracellular signaling pathways.
    Lai H; Rogers DF
    J Aerosol Med Pulm Drug Deliv; 2010 Aug; 23(4):219-31. PubMed ID: 20695774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of airway mucus hypersecretion.
    Rogers DF; Barnes PJ
    Ann Med; 2006; 38(2):116-25. PubMed ID: 16581697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pulmonary mucus: Pediatric perspective.
    Rogers DF
    Pediatr Pulmonol; 2003 Sep; 36(3):178-88. PubMed ID: 12910578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contribution of IL-18-induced innate T cell activation to airway inflammation with mucus hypersecretion and airway hyperresponsiveness.
    Ishikawa Y; Yoshimoto T; Nakanishi K
    Int Immunol; 2006 Jun; 18(6):847-55. PubMed ID: 16611648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of interleukin-25 (IL-17E)-induced pulmonary inflammation and airways hyper-reactivity.
    Sharkhuu T; Matthaei KI; Forbes E; Mahalingam S; Hogan SP; Hansbro PM; Foster PS
    Clin Exp Allergy; 2006 Dec; 36(12):1575-83. PubMed ID: 17177681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Airway mucus hypersecretion in asthma: an undervalued pathology?
    Rogers DF
    Curr Opin Pharmacol; 2004 Jun; 4(3):241-50. PubMed ID: 15140415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current and future therapies for airway mucus hypersecretion.
    Barnes PJ
    Novartis Found Symp; 2002; 248():237-49; discussion 249-53, 277-82. PubMed ID: 12568498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rosiglitazone, a peroxisome proliferator-activated receptor-gamma agonist, attenuates acrolein-induced airway mucus hypersecretion in rats.
    Liu DS; Liu WJ; Chen L; Ou XM; Wang T; Feng YL; Zhang SF; Xu D; Chen YJ; Wen FQ
    Toxicology; 2009 Jun; 260(1-3):112-9. PubMed ID: 19464576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytokine regulation of mucus production in a model of allergic asthma.
    Cohn L; Whittaker L; Niu N; Homer RJ
    Novartis Found Symp; 2002; 248():201-13; discussion 213-20, 277-82. PubMed ID: 12568496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bronchial epithelium as a target for innovative treatments in asthma.
    Gras D; Chanez P; Vachier I; Petit A; Bourdin A
    Pharmacol Ther; 2013 Dec; 140(3):290-305. PubMed ID: 23880290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of suplatast tosilate on goblet cell metaplasia in patients with asthma.
    Hoshino M; Fujita Y; Saji J; Inoue T; Nakagawa T; Miyazawa T
    Allergy; 2005 Nov; 60(11):1394-400. PubMed ID: 16197471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. STAT6-mediated signaling in Th2-dependent allergic asthma: critical role for the development of eosinophilia, airway hyper-responsiveness and mucus hypersecretion, distinct from its role in Th2 differentiation.
    Hoshino A; Tsuji T; Matsuzaki J; Jinushi T; Ashino S; Teramura T; Chamoto K; Tanaka Y; Asakura Y; Sakurai T; Mita Y; Takaoka A; Nakaike S; Takeshima T; Ikeda H; Nishimura T
    Int Immunol; 2004 Oct; 16(10):1497-505. PubMed ID: 15351784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Macrolides attenuate mucus hypersecretion in rat airways through inactivation of NF-kappaB.
    Ou XM; Feng YL; Wen FQ; Wang K; Yang J; Deng ZP; Liu DS; Li YP
    Respirology; 2008 Jan; 13(1):63-72. PubMed ID: 18197913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytokines in chronic obstructive pulmonary disease.
    Chung KF
    Eur Respir J Suppl; 2001 Dec; 34():50s-59s. PubMed ID: 12392035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of Th2-driven, allergen-induced airway inflammation by sauchinone.
    Min HJ; Won HY; Kim YC; Sung SH; Byun MR; Hwang JH; Hong JH; Hwang ES
    Biochem Biophys Res Commun; 2009 Jul; 385(2):204-9. PubMed ID: 19450563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physiology of airway mucus secretion and pathophysiology of hypersecretion.
    Rogers DF
    Respir Care; 2007 Sep; 52(9):1134-46; discussion 1146-9. PubMed ID: 17716382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of histamine on Th1/Th2 cytokine balance.
    Packard KA; Khan MM
    Int Immunopharmacol; 2003 Jul; 3(7):909-20. PubMed ID: 12810348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Th2-induced airway mucus production is dependent on IL-4Ralpha, but not on eosinophils.
    Cohn L; Homer RJ; MacLeod H; Mohrs M; Brombacher F; Bottomly K
    J Immunol; 1999 May; 162(10):6178-83. PubMed ID: 10229862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-1beta-induced mucin production in human airway epithelium is mediated by cyclooxygenase-2, prostaglandin E2 receptors, and cyclic AMP-protein kinase A signaling.
    Gray T; Nettesheim P; Loftin C; Koo JS; Bonner J; Peddada S; Langenbach R
    Mol Pharmacol; 2004 Aug; 66(2):337-46. PubMed ID: 15266025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.